Yau, T., Yao, T., Chan, P., Wong, H., Pang, R., Fan, S. T., & Poon, R. T. (2011). The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib. AlphaMed Press.
Citación estilo ChicagoYau, Thomas, T.J Yao, Pierre Chan, Hilda Wong, Roberta Pang, Sheung Tat Fan, and Ronnie T.P Poon. The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib. AlphaMed Press, 2011.
Cita MLAYau, Thomas, et al. The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib. AlphaMed Press, 2011.